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Thirty years ago Berkson recognized that differences in selection rates ofdifferent diseases for admission
to the hospital will systematically change the frequency with which those diseases co-exist in hospitalized
patients from the frequency rate in the general population. Mainland subsequently demonstrated that
postmortem studies systematically show a lower co-morbidity rate for any two individually lethal diseases
than would be expected from the individual prevalence of these diseases. In studying the concurrence of
bacterial endocarditis and cirrhosis, we examined the relationship of these diseases at autopsy where,
according to this concept, we would expect a negative association. We found the frequency of bacterial
endocarditis to be three times greater in cirrhotic than in non-cirrhotic patients, a statistically significant
difference that was even more convincing, since a negative correlation was anticipated. In accord with the
Berkson-Mainland hypothesis, however, no such association was seen between bacterial endocarditis and
either emphysema or myocardial infarction, two other chronic diseases of different lethality. Similarly,
glioblastoma multiforme, a brain tumor with a high mortality rate, showed a negative correlation with
cirrhosis, emphysema, and myocardial infarction. A corollary of this bias-that the mean age at death
should be lower in patients dying with two lethal diseases than in patientsdying ofeitherdisease alone-was
supported by our study. This investigation provides evidence to validate the Berkson-Mainland hypothesis,
and suggests that rather than being always an adverse bias, it may be used beneficially to document the
validity of the increased co-existence of diseases at autopsy.
Approximately thirty years ago Joseph Berkson described what has become
narrowly known as Berkson's fallacy [1]. His observations were not fallacious,
however, and discerning investigators tend to use the more alliterative term, the
Berkson bias. Berkson prefers the term "paradox."
Heperceived thatfor everydisease there exists a specificprobability that its victims
will be selected for admission to the hospital. If the selection rates, i.e., admission
rates, differ for different diseases, he reasoned, the ratio of multiple diagnoses to
single diagnoses will be different in hospitalized patients from those in the general
population. Selection rates may be influenced by factors such as the severity of
symptoms, or the reputation of a particular physician or hospital for a particular
disease, or these days, by the room rates at the hospital. Berkson showed mathemati-
cally that even if the probabilities for admission operated independently in individu-
als suffering from more than one disease, the coincidence of multiple diseases in
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hospital would differ from, and would tend.to occur together more frequently, than
in the parent population. Berkson's original example showed that although diabetes
occurs in the same percentage ofpatients with and without cholecystitis in thegeneral
population, different admission rates can result in almost twice the occurrence of
diabetes in hospitalized patients with cholecystitis as in patients without cholecystisis
[1]. He concluded his paper by stating that "The same results would appear if
sampling were applied to randomly distributed cards instead of patients" to show
that this phenomenon was mathematical, rather than biological.
Recently, Roberts and Sackett and their associates have, for the first time,
presented data that confirm Berkson's bias in the clinical setting [2].
In addition, calculations about the association of two diseases can be affected by
various selective factors after admission to hospital. For example, the avidity with
which diagnostic screening tests are used affects the apparent association ofdifferent
diseases. In a hospital in which the SMA-18, which measures serum glucose and urea
among other substances, is routinely used, subclinical elevations ofglucose and urea
levels will make the association of diabetes and uremia with each of the diseases that
precipitated admission higher than in the general population.
Mainland, a few years later, showed that the association oftwo diseases at autopsy
occurs less frequently than one would expect from the individual incidences of the
two diseases in the general population [3]. In essence, patients coming to autopsy
have been selected by death. Let us, for example, compare the frequency ofbacterial
endocarditis in patients with cirrhosis and in patients with emphysema according to
the theory of competing risks (Table 1). Assume that endocarditis occurs in 1% of
patients with cirrhosis and in 1% with emphysema. Assume that 14% ofthe cirrhotic
patients, 4% of the patients with emphysema, and 50% of those with bacterial
endocarditis die. Assume that these probabilities are independent of each other.
Assume that we study 10,000 cirrhotic and 10,000 emphysema patients and that all
deaths are followed by complete autopsy, that prosectors are infallible, and that all
reports are accurate, complete, and available.
One percent of the 10,000 cirrhotic patients, i.e., 100 patients, will have bacterial
endocarditis. Fourteen of them will die ofcirrhosis and 50% of the remaining 86 (or
TABLE I
ASSUMPTIONS:
There are 10,000 cirrhotic patients and 10,000 patients with emphysema.
Bacterial endocarditis occurs in 1% of each group.
Emphysema has a mortality rate of 4%.
Cirrhosis has a mortality rate of 14%0.
Bacterial endocarditis has a mortality rate of 50%0.




Cirrhosis 57 1,386 1,443
Emphysema 52 396 448
CONCLUSIONS:
Bacterial endocarditis is present in 57 of 1,443 patients who died with cirrhosis (4%).
Bacterial endocarditis is present in 52 of 448 patients who died with emphysema (12%).
This difference is highly significant p <0.001.
14243 patients) will die of endocarditis-thus a total of 57 of the cirrhotic patients will
have died. (Alternatively one can assume that the two diseases kill simultaneously.)
Calculating the other compartments similarly, one finds that endocarditis appears to
occur significantly less frequently in cirrhosis (4%) with its higher mortality than in
emphysema (12%), which is less lethal. Indeed, the coincidence of two individually
lethal diseases will occur at autopsy less frequently together than in the general
population. As a corollary, any disease under scrutiny will occur less frequently at
autopsy in association with a highly lethal disease than in association with a lowly
lethal disease. In the simplest sense, more patients will die of cirrhosis than of
emphysema before they have a chance to develop bacterial endocarditis.
Having presented the Berkson hypothesis, let's try it out in practice. Spontaneous
bacterial peritonitis is a disease of cirrhotic patients in which it is thought that
preexistent ascites becomes infected by blood-borne bacteria. It is believed that the
bacteremia in cirrhosis is prolonged because of portal-systemic shunting and that
prolonged bacteremia increases the risks of infection of the ascitic fluid. If this
proposed, serendipitous pathogenesis is correct, the incidence ofbacterial infection of
other susceptible sites should also be increased. We assumed the cardiac valves to be
such a site, and predicted that if the postulated pathogenesis was correct, bacterial




Because of the negative concurrence (or antagonism) between lethal diseases at
autopsy, we deliberately decided to study the coincidence ofcirrhosis and endocardi-
tis from the autopsy files of our hospital. All 4,215 autopsies at the West Haven
Veterans Administration Hospital (WHVAH) were reviewed for the presence or
absence of bacterial endocarditis and of cirrhosis, and the postmortem diagnosis in
each instance was confirmed blindly. The frequency of bacterial endocarditis in
patients with cirrhosis was compared with its frequency in non-cirrhotic patients. In
addition, we determined the frequency of occurrence ofendocarditis in patients with
acute myocardial infarction as a highly lethal control disease for cirrhosis, and with
pulmonary emphysema as a control disease of lower lethality. We also studied the
frequency of association ofglioblastoma multiforme as an uncommon but oftenfatal
disease, as a control for bacterial endocarditis. This brain tumor, which is not
thought to be pathogenically related to cirrhosis, myocardial infarction, or emphy-
sema, was observed with about the same frequency as bacterial endocarditis.
Clinical Study
We also compared the concurrence of bacterial endocarditis in cirrhotic and non-
cirrhotic patients based on clinical diagnoses at the WHVAH. It isdifficult, however,
to determine the precise number of patients admitted to a VA Hospital over any
given period. The Veterans Administration record-keeping system registers the
number of admissions to the hospital, but does not afford easy access to the number
of patients admitted per unit period of time. Furthermore, there is no constant
relationship between the number of patients admitted and the total number of
admissions. Because no simpler technique was available, the number of patients
admitted was estimated by the"yards ofcards" method. This estimateis based onthe
contents of the alphabetical admission file, which contains an index card for every
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patient has been admitted many times, he may have several cards stapled together.
After establishing the number of patients per cm of stacked cards, corrected for
staples and alphabetical markers, we determined the number of patients from the
total height ofthe stacked index cards. According to this method, 41,151 patients had
been admitted during the 20.5 year period of this study.
RESULTS
Postmortem Study
Bacterial endocarditis was seen in 1% of the autopsies, a figure similar to that
observed in other series (Table 2). Among the 557 cirrhotic patients, bacterial
endocarditis occurred in 1.8%, and among the non-cirrhotic patients in 0.9%. This
difference almost, but not quite, achieves statistical significance. The p value is less
than 0.06.
No such association was seen between bacterial endocarditis and either emphy-
sema or myocardial infarction or between glioblastoma multiforme and cirrhosis,
myocardial infarction, or emphysema (Fig. 1). By contrast, the anticipated antagon-
ism of Mainland at autopsy was observed between glioblastoma and cirrhosis,
glioblastoma and myocardial infarction, and glioblastoma and emphysema, and was
highly significant in each instance (Fig. 2).
Clinical Study
One-tenth of one percent of the non-cirrhotic patients had bacterial endocarditis
compared to 0.34% of the cirrhotic patients. This difference is highly statistically
significant (p < 0.001) (Table 3).
To be certain that our"yards ofcards" estimate ofthe number ofpatients admitted
did not affect the results, we repeated the calculations assuming that the estimate of
admissions was both half and twice the true number. The differences remain highly
significantly different (p < 0.001).
DISCUSSION
Postmortem Study
Although the positive association between cirrhosis and bacterial endocarditis in
the autopsy study did not achieve statistical significance by conventional standards,
one might extrapolate, and say that ap value of< 0.06 is statistically significantfor a
positive association when one would have expected a statistically significant negative
association. Are statistics available for such calculations? Unless one has for com-
parison a control disease with the same rate ofadmission to the hospital and the same
TABLE 2
Association of Cirrhosis and Bacterial Endocarditis at the WHVAH (Autopsy Study)
Bacterial
Total Endocarditis
Group No. No. %
All autopsies 4215 44 1.0
Cirrhosis 557 10 1.8
No cirrhosis 3658 34 0.9 P0

















FIG. 1. Postmortem association ofbacterial endocarditis with cirrhosis, emphysemaandmyocardialinfarction. The
height ofthe bars represents the percentages of patients in each subgroup. Thep value indicates the degree ofstatistical
significance by X 2 analysis. Although bacterial endocarditis occurred significantly more commonly in cirrhotic than
in non-cirrhotic patients, no such association of endocarditis with emphysema or myocardial infarction was observed.
GLIOBLASTOMA MULTIFORME
p <.01 P< .01






FIG. 2. Postmortem association ofglioblastoma multiforme with cirrhosis, emphysema andmyocardial infarction.
Thep value indicates the degree of statistical significance by X2 analysis. Statistically significant negative associations of
glioblastoma multiforme with cirrhosis, with emphysema and with myocardial infarction demonstrate the Berkson-
Mainland bias.TABLE 3
Association of Cirrhosis and Bacterial Endocarditis at the WHVAH (Clinical Study)
Patients with
Total Patients Endocarditis
Group No. % No. %
All patients 41,151 100.0 52 0.13
Cirrhosis 3,806 9.2 13 0.34 p 001
No cirrhosis 37,345 90.8 39 0.10
mortality rate, and one that itself is not pathogenically related to the disease under
evaluation, and unless the rate is known, such calculations cannot be done. Since
such control groups are not available, one cannot calculate statistical significance.
An old adage states, "Alcohol keeps the pipes clean." There are numerous
postmortem publications to confirm this negative relationship[4-6]. In our postmor-
tem study, cirrhosis was observed in 9% of the patients without myocardial infarc-
tion, but in only 2% of those with acute myocardial infarction. This difference is
highly statistically significant (p < 0.001). No such association was seen, however,
between emphysema and cirrhosis orbetween emphysema and myocardial infarction.
Perhaps the antagonism between myocardial infarction and cirrhosis can be better
explained by the Berkson bias than by the solubility of atherosclerotic lipids in
ethanol.
If the Berkson-Mainland hypothesis of antagonism among multiple diseases at
autopsy is correct, one might expect that the mean age ofthepatients at deathwould
be lower for those with a single disease at autopsy than for those with two diseases,
despite the fact that age at death is also affected by many other factors. This
hypothesis was found to be true in almost all instances in our study (Table 4). The
mean age of patients who died of cirrhosis alone was significantly lower than that of
thosewho diedwith both cirrhosis and bacterial endocarditis (55.8 ±0.5 vs. 62.3 ± 3.0,
p < 0.05). Similarly, the mean age of patients who died of cirrhosis alone was lower
than those who died ofcirrhosis and myocardial infarction(55.8 ± 0.5 vs. 60.3 ± 3.3,p
< 0.05). The mean age ofpatients at death ofglioblastoma multiforme alone was 52.5
years, a figure far lower than for those who died with glioblastoma and cirrhosis
(59.0), and glioblastoma and emphysema (57.9). There were no patients with both
glioblastoma and myocardial infarction. These data support the concept that the
earlier death in patients with lethal diseases can cause the decreased coincidence of
multiple lethal disorders.
TABLE 4
Mean Age at Autopsy
No. of Age
Disease Patients Mean ± SEM
Glioblastoma multiforme 61 52.5 ± 1.5
Cirrhosis 557 55.9 ± 0.5
Bacterial endocarditis 44 59.5 ± 1.9
Myocardial infarction 356 62.7 ± 0.6
Pulmonary emphysema 1,680 64.0 ± 0.5
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Clinical Study
Since one would expect an increased association between cirrhosis and bacterial
endocarditis on the basis of Berkson's bias in the clinical study, it is difficult to know
whether this degree of statistical significance (p < 0.001) is above and beyond the
level expected. Unless one had another disease with exactly the same selection rate as
cirrhosis, but had no pathogenic relationship to bacterial endocarditis, this question
cannot be answered. In a completely computerized medical record-keeping system it
might, perhaps, be possible to compare the frequency ofthe association of bacterial
endocarditis and cirrhosis with that of bacterial endocarditis and a number of other
chronic diseases. If none of the others showed a positive association or approached
this high degree of togetherness, one might conclude that the absence of such a
relationship over a whole spectrum ofselection values would support the coincidence
of endocarditis and cirrhosis.
We believe that our data support the concept that bacterial endocarditis occurs
with increased frequency in cirrhotic patients, and that this fact provides clinical
validation for the postulated pathogenesis. Other data from these studies demon-
strate that bacterial endocarditis in cirrhotic patients differs from the endocarditis of
non-cirrhotic patients in terms of underlying valvular disease and in the species of
organisms responsible.
We know that hospital samples are biased samples, i.e., they are not representative
of the general population of sick people, which in turn is a biased sample of the
parent population. Autopsy samples are doubly biased. It is unlikely that unbiased
conclusions can be derived from biased samples.
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